0001753926-24-000984.txt : 20240515 0001753926-24-000984.hdr.sgml : 20240515 20240515163919 ACCESSION NUMBER: 0001753926-24-000984 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240514 FILED AS OF DATE: 20240515 DATE AS OF CHANGE: 20240515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaufman Jonathan H CENTRAL INDEX KEY: 0001959250 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41575 FILM NUMBER: 24951958 MAIL ADDRESS: STREET 1: C/O LIPELLA PHARMACEUTICALS INC. STREET 2: 7800 SUSQUEHANNA ST., SUITE 505 CITY: PITTSBURGH STATE: PA ZIP: 15208 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIPELLA PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001347242 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 N LEXINGTON ST STREET 2: STE LL103 CITY: PITTSBURGH STATE: PA ZIP: 15208 BUSINESS PHONE: 412-901-0315 MAIL ADDRESS: STREET 1: 400 N LEXINGTON ST STREET 2: STE LL103 CITY: PITTSBURGH STATE: PA ZIP: 15208 FORMER COMPANY: FORMER CONFORMED NAME: LIPELLA PHARMACEUTICALS INC DATE OF NAME CHANGE: 20051219 4 1 ownership.xml X0508 4 2024-05-14 0 0001347242 LIPELLA PHARMACEUTICALS INC. LIPO 0001959250 Kaufman Jonathan H C/O LIPELLA PHARMACEUTICALS INC. 7800 SUSQUEHANNA ST., SUITE 505 PITTSBURGH PA 15208 1 1 1 0 See remarks below. 0 Common Stock 2024-05-14 4 P 0 10000 0.759 A 898849 D Open market purchase by the reporting person of 10,000 shares of common stock, par value $0.0001 per share (the "Common Stock"). Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on May 14, 2024 at prices ranging from $0.7552 to $0.76 per share, inclusive. The amount reflected has been rounded to 3 decimal points. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range. President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors /s/ Jonathan H. Kaufman 2024-05-15